Takeda Pharmaceutical Books Second-Quarter Net Loss
Wall Street Journal
Takeda Pharmaceutical reported a second-quarter net loss due to impairment losses on certain products and cut its net-profit forecast for the fiscal year ending March 2024.
https://www.wsj.com/articles/takeda-pharmaceutical-books-second-quarter-net-loss-aa5b51dc